Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the unaudited financials (standalone ....

Date: 25th July 2026 National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM Sub: Intimation for Board Meeting Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, This is to inform that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 4th August 2026, interalia. - To consider, approve and take on record, Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June 2026 along with other business items. It is further informed that pursuant to the provisions of the “Code of Internal Procedure and Conduct of Regulating, Monitoring and Reporting of Trading in Securities by Insiders” (“The Code”) adopted by the Company, read with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window was closed for persons covered under the Code, from Wednesday, 1st July 2026 till 48 hours from the declaration of Unaudited Financial Results for the Quarter ended on 30th June 2026. Pursuant to the same, the period of closure of the Trading Window is as under: From: Wednesday , 1st July 2026 Till: Thursday, 6th August 2026 (Both days inclusive) Kindly take note of the same. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com